{
    "nctId": "NCT02727868",
    "briefTitle": "Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans",
    "officialTitle": "Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans",
    "overallStatus": "COMPLETED",
    "conditions": "Patient With Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "analysis of the frequency of granulocytes PIG-A mutated",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Major patients,\n* The patients achieving a breast cancer\n* Patients who have benefited from a breast surgery\n* Patients to have an external adjuvant radiotherapy.\n* Patients being able to read and understand French.\n* Patients beneficiaries of a social security scheme.\n* Pregnant women can not participate in this study. A pregnancy test should only be prescribed when clinically indicated, regardless of the course of the study.\n* Patients who received information and signed informed consent\n\nExclusion Criteria:\n\nPatients who received chemotherapy before radiation therapy.\n\n* Minor patients\n* Patients who do not speak French and / or unable to read and understand French.\n* Patients who have had radiotherapy history\n* Patients who have had a history of chemotherapy\n* Patients who have not received the information and had not signed informed consent for participation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}